Genetic Technologies Ltd.
GENE
GENE was delisted on the 16th of October, 2024.
7 hedge funds and large institutions have $160K invested in Genetic Technologies Ltd. in 2013 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
17% more funds holding
Funds holding: 6 → 7 (+1)
8% less capital invested
Capital invested by funds: $174K → $160K (-$14K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
APU
Alpine Partners USVI
St. Thomas,
U.S. Virgin Islands
|
+$26.2K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.38K |
| 3 |
U
UBS
Zurich,
Switzerland
|
+$1.43K |
| 4 |
Citigroup
New York
|
+$952 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Aperio Group
Sausalito,
California
|
-$29.8K |
| 2 |
Group One Trading
Chicago,
Illinois
|
-$6.43K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AG
1
Aperio Group
Sausalito,
California
| $55K | -$29.8K | -125 | -34% |
|
|
APU
2
Alpine Partners USVI
St. Thomas,
U.S. Virgin Islands
| $49K | +$26.2K | +110 | +109% |
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $26K | – | – | – |
|
|
VKH
4
Virtu KCG Holdings
New York
| $25K | +$25.7K | +108 | New |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $3K | +$2.38K | +10 | +200% |
|
|
6
Citigroup
New York
| $1K | +$952 | +4 | New |
|
|
U
7
UBS
Zurich,
Switzerland
| $1K | +$1.43K | +6 | New |
|
|
8
Group One Trading
Chicago,
Illinois
| – | -$6.43K | -27 | Closed |
|
GENE Hedge Fund Activity: Q3 2013 in Review
7 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q3 2013, worth a combined $160K — down 8% from $174K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new GENE positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Alpine Partners USVI, adding an estimated $26.2K. The largest seller was Aperio Group, cutting an estimated $29.8K.
- 7 institutional investors held Genetic Technologies Ltd. (GENE) as of Q3 2013, up from 6 in Q2 2013.
- Funds reported $160K of Genetic Technologies Ltd. stock for Q3 2013, down 8% quarter-over-quarter.
- 3 funds opened new Genetic Technologies Ltd. positions in Q3 2013 and 1 closed out, a net change of +2 holders.
- The largest Genetic Technologies Ltd. buyer in Q3 2013 was Alpine Partners USVI, an estimated $26.2K added.
- The largest Genetic Technologies Ltd. seller in Q3 2013 was Aperio Group, an estimated $29.8K sold.
Based on aggregated 13F filings for Q3 2013.